Back to Search Start Over

Escherichia coli from biopsies differ in virulence genes between patients with colorectal neoplasia and healthy controls.

Authors :
Bosák J
Kohoutová D
Hrala M
Křenová J
Morávková P
Rejchrt S
Bureš J
Šmajs D
Source :
Frontiers in microbiology [Front Microbiol] 2023 Apr 13; Vol. 14, pp. 1141619. Date of Electronic Publication: 2023 Apr 13 (Print Publication: 2023).
Publication Year :
2023

Abstract

Introduction: Pathogenic strains of Escherichia coli have been clearly identified as the causative agents of extraintestinal and diarrheal infections; however, the etiopathogenic role of E. coli in other conditions, including colorectal cancer, remains unclear.<br />Methods: This study aimed to characterize mucosal E. coli isolates ( n = 246) from 61 neoplasia patients and 20 healthy controls for the presence of 35 genetic determinants encoding known virulence factors.<br />Results: Virulence determinants encoding invasin ( ibeA ), siderophore receptor ( iroN ), S-fimbriae ( sfa ), and genotoxin ( usp ) were more prevalent among E. coli isolated from patients with neoplasia compared to the control group ( p < 0.05). In addition, the prevalence of these virulence determinants was increased in more advanced neoplasia stages ( p <subscript>adj</subscript> < 0.0125). Compared to patients with advanced colorectal adenoma and carcinoma, the ibeA gene was rarely found in the control group and among patients with non-advanced adenoma ( p < 0.05), indicating its potential as the advanced-neoplasia biomarker. Patients with neoplasia frequently had E. coli strains with at least one of the abovementioned virulence factors, whereby specific combinations of these virulence factors were found.<br />Discussion: These findings suggest that E. coli strains isolated from patients with colorectal neoplasia possess several virulence factors, which could contribute to the development of neoplastic processes in the large intestine.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 Bosák, Kohoutová, Hrala, Křenová, Morávková, Rejchrt, Bureš and Šmajs.)

Details

Language :
English
ISSN :
1664-302X
Volume :
14
Database :
MEDLINE
Journal :
Frontiers in microbiology
Publication Type :
Academic Journal
Accession number :
37125208
Full Text :
https://doi.org/10.3389/fmicb.2023.1141619